The Problem with Fast-Tracking Drug Approvals: Pharmas Fail to Follow Up
To get potentially lifesaving drugs to patients faster, the U.S. Food and Drug Administration is allowed to approve some drugs — those that address unmet medical needs — based on fewer trials than usual. But it turns out that…